Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LBRXLB PHARMACEUTICALS INC

Nasdaq · CIK 0001691082
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts204

Identity from submissions API

NameLB PHARMACEUTICALS INC
CIK0001691082
TickersLBRX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone917-450-6581
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • LB PHARMACEUTICALS INC. (2016-12-15T05:00:00.000Z → 2018-12-12T05:00:00.000Z)
Business address
575 MADISON AVENUE
NEW YORK
NY
10022
NY
Mailing address
575 MADISON AVENUE
NEW YORK
NY
10022
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

146 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-464051 005-95235 261563412 34 14597
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000053 005-95235 261562745 34 15588
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-052394 005-95235 261561122 34 11869
2026-11-05 10-Q 10-Q 0001193125-26-449994 001-42831 261527950 34 15543185 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-449887 001-42831 261527586 34 215901 1 1
2026-10-13 4 xslF345X06/form4-10132026_041004.xml 0001746372-26-000007 5908
2026-10-13 4 xslF345X06/form4-10132026_041001.xml 0002150267-26-000005 5852
2026-10-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000019617-26-000360 005-95235 261456291 34 6940
2026-10-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003150 333-294900 261442234 33 1817
2026-10-01 POS AM POS AM 0001193125-26-410664 333-294900 261431416 33 20131
2026-10-01 S-3ASR S-3ASR 0001193125-26-410651 333-299235 261431359 33 2249817 1 1
2026-09-24 3 xslF345X06/form3-09242026_080952.xml 0002150267-26-000003 10047
2026-09-15 424B3 424B3 0001193125-26-391384 333-294900 261379190 33 39665
2026-09-15 8-K 8-K 5.02,7.01,9.01 0001193125-26-391358 001-42831 261379166 34 174695 1 1
2026-09-14 3 xslF345X06/form3-09142026_080925.xml 0001746372-26-000005 10110
2026-09-03 424B3 424B3 0001193125-26-381100 333-294900 261356763 33 38680
2026-09-03 8-K 8-K 5.02,7.01,9.01 0001193125-26-381076 001-42831 261356748 34 174495 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352336 005-95235 261282087 34 14451
2026-08-11 424B3 424B3 0001193125-26-343542 333-294900 261260795 33 3304581
2026-08-11 10-Q 10-Q 0001193125-26-343490 001-42831 261260703 34 12924069 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-343479 001-42831 261260694 34 211342 1 1
2026-08-03 4 4 0001193125-26-331058 12977
2026-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002809 005-95235 261216899 34 10901
2026-07-29 424B3 424B3 0001193125-26-322276 333-294900 261214096 33 44718
2026-07-29 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-26-322208 001-42831 261214037 34 623191 1 1
2026-07-22 424B3 424B3 0001193125-26-311394 333-294900 261191795 33 29359
2026-07-22 8-K 8-K 8.01,9.01 0001193125-26-311357 001-42831 261191702 34 162860 1 1
2026-07-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000019617-26-000264 005-95235 261180350 34 7160
2026-06-10 424B3 424B3 0001193125-26-266020 333-294900 261080500 33 36583
2026-06-10 8-K 8-K 5.02,9.01 0001193125-26-265867 001-42831 261079877 34 219880 1 1
2026-06-09 144 xsl144X01/primary_doc.xml 0001972481-26-000189 001-42831 261077299 33 4285
2026-06-09 424B3 424B3 0001193125-26-263737 333-294900 261076150 33 65572
2026-06-09 8-K 8-K 5.07 0001193125-26-263724 001-42831 261076079 34 147011 1 1
2026-06-05 4 xslF345X06/form4-06052026_100631.xml 0001187308-26-000002 5671
2026-06-05 4 xslF345X06/form4-06052026_090603.xml 0001609805-26-000003 5686
2026-06-05 4 xslF345X06/form4-06052026_090613.xml 0002031342-26-000002 5685
2026-06-05 4 xslF345X06/form4-06052026_090641.xml 0001992908-26-000011 5954
2026-06-05 4 xslF345X06/form4-06052026_090613.xml 0001771213-26-000002 5651
2026-06-05 4 xslF345X06/form4-06052026_090647.xml 0001813937-26-000003 5702
2026-06-05 4 xslF345X06/form4-06052026_090631.xml 0001533228-26-000006 5665
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226892 005-95235 26988272 34 13522
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000020 005-95235 26987483 34 15589
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001727492-26-000009 005-95235 26983816 34 9963
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000019617-26-000216 005-95235 26971682 34 7154
2026-05-12 424B3 424B3 0001193125-26-219851 333-294900 26969848 33 2677725
2026-05-12 10-Q 10-Q 0001193125-26-219607 001-42831 26969156 34 10821595 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001193125-26-219529 001-42831 26968934 34 199733 1 1
2026-04-23 ARS ARS 0001193125-26-173732 001-42831 26888809 34 5551736
2026-04-23 DEFA14A DEFA14A 0001193125-26-173708 001-42831 26888746 34 1007224
2026-04-23 DEF 14A DEF 14A 0001193125-26-173679 001-42831 26888652 34 1503076 1 1
2026-04-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001186 333-294900 26862415 33 1803
2026-04-14 424B3 424B3 0001193125-26-155011 333-294900 26861362 33 686625
2026-04-10 CORRESP filename1.htm 0001193125-26-151255 6868
2026-04-10 UPLOAD filename1.pdf 0000000000-26-003643 333-294900 40107
2026-04-06 S-1 S-1 0001193125-26-143724 333-294900 26841198 33 950504 1 1
2026-03-26 S-8 S-8 0001193125-26-126539 333-294656 26799164 33 236825 1 1
2026-03-26 10-K 10-K 0001193125-26-126368 001-42831 26798755 34 21258603 1 1
2026-03-26 8-K 8-K 2.02,9.01 0001193125-26-126223 001-42831 26798185 34 211143 1 1
2026-03-16 8-K 8-K 5.02 0001193125-26-108474 001-42831 26757455 34 143700 1 1
2026-03-10 4 xslF345X05/form4-03102026_080331.xml 0001992908-26-000007 5550
2026-03-10 3 xslF345X02/form3-03102026_080333.xml 0001992908-26-000005 9893
2026-03-10 8-K 8-K 5.02,7.01,9.01 0001193125-26-099419 001-42831 26737295 34 164544 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-26-000049 005-95235 26642425 34 14543
2026-02-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-044781 005-95235 26616505 34 16969
2026-02-10 4 4 0001193125-26-044776 15069
2026-02-05 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001193125-26-038539 001-42831 26600633 34 613686 1 1
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000685 005-95235 26545912 34 10727
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-26-000189 005-95235 26545737 34 10736
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000019617-26-000044 005-95235 26544852 34 6726
2025-12-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-029833 005-95235 251617884 34 24379
2025-12-11 4 xslF345X05/form4-12112025_041206.xml 0002095250-25-000006 5779
2025-11-18 3 xslF345X02/form3-11182025_111154.xml 0002095250-25-000002 9397
2025-11-13 8-K 8-K 1.01,9.01 0001193125-25-279074 001-42831 251475551 34 227289 1 1
2025-11-12 8-K 8-K 8.01,9.01 0001193125-25-276070 001-42831 251469193 34 159458 1 1
2025-11-06 10-Q 10-Q 0001193125-25-268174 001-42831 251456317 34 11412120 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-268154 001-42831 251456290 34 229297 1 1
2025-10-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003591 005-95235 251399658 34 10686
2025-09-29 4 xslF345X05/form4-09302025_120930.xml 0001304340-25-000006 28139
2025-09-29 3 xslF345X02/form3-09302025_120959.xml 0001304340-25-000004 15295
2025-09-25 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-091474 005-95235 251340908 34 26497
2025-09-19 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-25-000005 005-95235 251327414 34 18792
2025-09-19 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-209153 005-95235 251327199 34 423124
2025-09-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-207440 005-95235 251323747 34 115272
2025-09-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000020 005-95235 251323418 34 15008
2025-09-16 4 xslF345X05/form4-09162025_100907.xml 0002015536-25-000007 15060
2025-09-16 3 xslF345X02/form3-09162025_100901.xml 0002077950-25-000004 5161
2025-09-16 4 xslF345X05/form4-09162025_040904.xml 0001726334-25-000003 11458
2025-09-16 4 xslF345X05/form4-09162025_040901.xml 0001609805-25-000006 11205
2025-09-16 4 4 0001193125-25-204935 24581
2025-09-12 4 xslF345X05/form4-09122025_060919.xml 0001415889-25-024452 5493
2025-09-12 4 xslF345X05/form4-09122025_060917.xml 0001415889-25-024451 5527
2025-09-12 4 xslF345X05/form4-09122025_060915.xml 0001415889-25-024450 5544
2025-09-12 4 xslF345X05/form4-09122025_060913.xml 0001415889-25-024449 19140
2025-09-12 4 xslF345X05/form4-09122025_060911.xml 0001415889-25-024448 27929
2025-09-12 4 xslF345X05/form4-09122025_100911.xml 0001415889-25-024447 5528
2025-09-12 4 xslF345X05/form4-09122025_060909.xml 0001415889-25-024446 15217
2025-09-12 4 xslF345X05/form4-09122025_060907.xml 0001415889-25-024445 10767
2025-09-12 4 xslF345X05/form4-09122025_060905.xml 0001415889-25-024444 15331
2025-09-12 4 xslF345X05/form4-09122025_060903.xml 0001415889-25-024443 10842
2025-09-12 4 xslF345X05/form4-09122025_060901.xml 0001415889-25-024442 14995
2025-09-12 8-K 8-K 5.03,9.01 0001193125-25-202195 001-42831 251311540 34 185542 1 1
2025-09-12 424B4 424B4 0001193125-25-201757 333-289812 251310021 33 6788857
2025-09-11 3 xslF345X02/form3-09112025_100919.xml 0001415889-25-024307 9799
2025-09-11 3 xslF345X02/form3-09112025_030927.xml 0001415889-25-024255 5965
2025-09-11 3 xslF345X02/form3-09112025_010950.xml 0001415889-25-024247 10902
2025-09-11 S-8 S-8 0001193125-25-200401 333-290180 251306956 33 266144 1 1
2025-09-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002913 333-289812 251307153 33 1804
2025-09-10 3 xslF345X02/form3-09112025_120941.xml 0001415889-25-024200 22295
2025-09-10 S-1MEF S-1MEF 0001193125-25-200422 333-290182 251306998 33 187397 1 1
2025-09-10 3 xslF345X02/form3-09102025_110950.xml 0001415889-25-024192 9849
2025-09-10 3 xslF345X02/form3-09102025_110936.xml 0001415889-25-024190 9012
2025-09-10 3 xslF345X02/form3-09102025_110937.xml 0001415889-25-024188 8303
2025-09-10 3 xslF345X02/form3-09102025_110926.xml 0001415889-25-024186 11191
2025-09-10 3 xslF345X02/form3-09102025_110914.xml 0001415889-25-024184 8276
2025-09-10 3 xslF345X02/form3-09102025_110945.xml 0001415889-25-024181 8321
2025-09-10 3 xslF345X02/form3-09102025_110950.xml 0001415889-25-024179 11168
2025-09-10 3 xslF345X02/form3-09102025_110949.xml 0001415889-25-024177 16283
2025-09-10 3 xslF345X02/form3-09102025_110936.xml 0001415889-25-024175 12925
2025-09-10 3 xslF345X02/form3-09102025_110935.xml 0001415889-25-024173 11903
2025-09-10 CERT LBRX_8A_Cert_1691082.pdf 0001354457-25-000881 001-42831 251305167 34 123936
2025-09-09 CORRESP filename1.htm 0001193125-25-198853 10802
2025-09-09 CORRESP filename1.htm 0001193125-25-198852 7376
2025-09-09 8-A12B 8-A12B 0001193125-25-198793 001-42831 251301662 34 14319
2025-09-08 S-1/A S-1/A 0001193125-25-197877 333-289812 251298829 33 8466890 1 1
2025-09-03 CORRESP filename1.htm 0001193125-25-195145 62495
2025-08-22 CORRESP filename1.htm 0001193125-25-186474 17881
2025-08-22 S-1 S-1 0001193125-25-186467 333-289812 251246931 33 11319621 1 1
2025-08-12 UPLOAD filename1.pdf 0000000000-25-008434 377-07237 43842
2025-07-23 DRSLTR filename1.htm 0000950123-25-006558 15520
2025-07-23 DRS/A filename1.htm 0000950123-25-006557 377-07237 251143906 33 6417328
2024-07-02 UPLOAD filename1.pdf 0000000000-24-007549 377-07237 42983
2024-06-24 DRSLTR filename1.htm 0000950123-24-006301 64191
2024-06-24 DRS/A filename1.htm 0000950123-24-006300 377-07237 241064147 33 4899992
2024-06-17 UPLOAD filename1.pdf 0000000000-24-006957 377-07237 67509
2024-05-20 DRS filename1.htm 0000950123-24-005777 377-07237 24966002 33 7872728
2024-01-10 D/A xslFormDX01/primary_doc.xml 06b 0001691082-24-000001 021-492682 24526340 33 13984
2023-09-21 D xslFormDX01/primary_doc.xml 06b 0001691082-23-000004 021-492682 231268503 33 13869
2022-11-23 D/A xslFormDX01/primary_doc.xml 06b 0001567619-22-020814 021-463476 221415219 33 10107
2022-11-01 D xslFormDX01/primary_doc.xml 06b 0001567619-22-018986 021-463476 221349496 33 10009
2022-07-06 D xslFormDX01/primary_doc.xml 06b 0001567619-22-013710 021-451258 221067935 33 10048
2020-09-01 D xslFormDX01/primary_doc.xml 06b 0001567619-20-016229 021-374620 201154399 33 10000
2018-12-12 D xslFormDX01/primary_doc.xml 06b 0001691082-18-000003 021-327722 181230581 33 12124
2018-08-27 D xslFormDX01/primary_doc.xml 06b 0001691082-18-000002 021-320086 181038605 33 9085
2018-05-29 D xslFormDX01/primary_doc.xml 06b 0001691082-18-000001 021-313419 18864240 33 9200
2017-04-06 D xslFormDX01/primary_doc.xml 06b 0001691082-17-000001 021-284184 17744737 33 9084
2016-12-15 D xslFormDX01/primary_doc.xml 06b 0001691082-16-000001 021-276363 162052970 33 9096

Latest XBRL company facts

One latest value per concept from companyfacts (204 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 32.36M 2026-11-03 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
ffd NetFeeAmt NetFeeAmt USD 31,357.6 2026-10-01 S-3ASR 2026-10-01 0001193125-26-410651
ffd TtlFeeAmt TtlFeeAmt USD 45,001.54 2026-10-01 S-3ASR 2026-10-01 0001193125-26-410651
ffd TtlOfferingAmt TtlOfferingAmt USD 517.26M 2026-10-01 S-3ASR 2026-10-01 0001193125-26-410651
ffd TtlOffsetAmt TtlOffsetAmt USD 13,643.94 2026-10-01 S-3ASR 2026-10-01 0001193125-26-410651
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-01 S-3ASR 2026-10-01 0001193125-26-410651
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 441,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 101,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268174
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 22.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 723,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -545,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 677.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.67M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 504,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap Assets Assets USD 453.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AssetsCurrent Assets, Current USD 447.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 546,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 403.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 310.74M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268174
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 215.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 403.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 215.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 215.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -35.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD -804,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 116,939 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 32.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 32.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap CommonStockValue Common Stock, Value, Issued USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -130.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 0 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 189.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 531,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 30.20M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 531,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 14.91M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 70.30M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 41.70M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 4.87M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.14M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 29.67M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 35,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap Depreciation Depreciation USD 303,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 321,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.28M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.28M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.249 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.021 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 3.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -1.60M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments USD -804,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD -200,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219607
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 28.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -129.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap IncomeTaxesPaid Income Taxes Paid USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 22.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -217,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -216,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 29.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 9.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap LandSubjectToGroundLeases Land Subject to Ground Leases sqft 4,600 2025-11-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LeaseCost Lease, Cost USD 580,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 6.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 968,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 775,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 254,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap Liabilities Liabilities USD 35.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 453.37M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap LiabilitiesCurrent Liabilities, Current USD 30.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 44.68M 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 234.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -144.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -125.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -129.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -129.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 8.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingExpenses Operating Expenses USD 138.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingLeaseCost Operating Lease, Cost USD 573,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 956,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingLeasePayments Operating Lease, Payments USD 548,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.096 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 161,000 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -713,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -731,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 709,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 9.75M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 465,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 166.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent Liability, Pension and Other Postretirement and Postemployment Benefits, Current USD 798,000 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 43.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PrepaidInsurance Prepaid Insurance USD 460,000 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 250.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 2.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities USD 10.20M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 20.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 2.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 1.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 59,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 60,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap RecapitalizationCosts Recapitalization Costs USD 0 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268174
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 110.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap RestrictedCash Restricted Cash USD 788,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 788,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap RestructuringCharges Restructuring Charges USD 700,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268174
us-gaap RestructuringReserve Restructuring Reserve USD 445,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -259.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap SeveranceCosts1 Severance Costs USD 967,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 11.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 23 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.867 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.044 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 15.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 100,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 100,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 981,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 35.14 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-343490
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 66.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 19.26 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 729,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 15.68 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 19.26 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 27.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap SharePrice Share Price USD/shares 34.94 2026-07-28 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 34.94 2026-07-28 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShortTermInvestments Short-term Investments USD 188.69M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219607
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 417.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 1,433 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 464 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 114.26M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 71,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 302.31M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 9,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 114.26M 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 120.48M 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 79.25M 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 78.07M 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 78.07M 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368
us-gaap VariableLeaseCost Variable Lease, Cost USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 30.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 30.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 30.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-449994
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126368

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →